VULVAR SQUAMOUS CELL CARCINOMA
Clinical trials for VULVAR SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new VULVAR SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for VULVAR SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancers? EVOLVE104 enters human testing
Disease control Recruiting nowThis early-stage trial tests a new drug called EVOLVE104 in 160 people with advanced bladder cancer or several types of squamous cell cancer that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Vulvar cancer breakthrough: biomarkers may spare or intensify surgery
Knowledge-focused Recruiting nowThis study looks at whether the type of early-stage vulvar cancer, based on HPV and p53 status, needs more or less surgery than usual. About 249 adults with stage I-II vulvar squamous cell carcinoma will be followed for 3 years to see how often cancer returns. The goal is to pers…
Matched conditions: VULVAR SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC